Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Johnson & Johnson, consolidated cash flow statement (quarterly data)

US$ in millions

3 months ended:	Dec 28, 2025	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Dec 29, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 1, 2023	Jul 2, 2023	Apr 2, 2023	Dec 31, 2022	Oct 2, 2022	Jul 3, 2022	Apr 3, 2022	Dec 31, 2021	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021
Net earnings (loss)	5,116)	5,152)	5,537)	10,999)	3,431)	2,694)	4,686)	3,255)	4,049)	26,028)	5,144)	(68)	3,520)	4,458)	4,814)	5,149)	4,736)	3,667)	6,278)	6,197)
Depreciation and amortization of property and intangibles	2,011)	1,777)	1,943)	1,772)	1,896)	1,846)	1,782)	1,815)	1,843)	1,829)	1,934)	1,880)	1,772)	1,685)	1,744)	1,769)	1,843)	1,814)	1,839)	1,894)
Stock based compensation	309)	347)	410)	288)	238)	295)	341)	302)	178)	296)	382)	306)	213)	281)	366)	278)	215)	259)	354)	307)
Asset write-downs	81)	93)	—)	30)	26)	—)	194)	185)	475)	432)	(38)	426)	429)	40)	137)	610)	25)	938)	12)	14)
Charges for purchase of in-process research and development assets	—)	17)	76)	16)	589)	1,252)	—)	—)	483)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Gain on Kenvue separation	—)	—)	—)	—)	—)	—)	—)	—)	—)	(20,984)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Net gain on sale of assets/businesses	(132)	(57)	1)	(75)	(1)	(2)	(223)	—)	—)	(70)	(39)	(8)	(167)	—)	(45)	(168)	(16)	—)	(21)	(580)
Deferred tax provision	(3,677)	2,218)	825)	2,172)	(16)	90)	(695)	(1,562)	(2,412)	560)	(799)	(1,543)	825)	(139)	(1,423)	(926)	485)	(1,879)	45)	(730)
Credit losses and accounts receivable allowances	5)	(9)	7)	(4)	22)	(11)	—)	—)	—)	—)	(1)	1)	(3)	(11)	(9)	6)	12)	(8)	(39)	(13)
(Increase) decrease in accounts receivable	391)	111)	(1,357)	(926)	853)	(96)	(884)	(279)	227)	(252)	(545)	(54)	301)	(205)	(959)	(427)	(584)	(252)	38)	(1,604)
(Increase) decrease in inventories	(46)	(748)	(510)	(146)	(90)	(299)	(391)	(348)	124)	(706)	(217)	(524)	(650)	(620)	(657)	(600)	(70)	(360)	(123)	(695)
Increase (decrease) in accounts payable and accrued liabilities	1,266)	1,997)	1,240)	(2,126)	(1,092)	2,264)	2,932)	(2,483)	1,682)	1,725)	1,511)	(2,572)	957)	1,311)	1,647)	(2,817)	2,255)	4,232)	(1,714)	(2,336)
(Increase) decrease in other current and non-current assets	1,486)	(1,459)	(4,877)	(1,317)	768)	(2,782)	532)	3,199)	(2,114)	(222)	(229)	(915)	(3,876)	1,036)	2,532)	995)	(4,046)	667)	(1,107)	2,522)
Increase (decrease) in other current and non-current liabilities	499)	(270)	583)	(6,509)	359)	2,742)	(2,641)	(427)	3,328)	(1,147)	(2,921)	6,328)	2,029)	(1,552)	(2,566)	110)	877)	(788)	(248)	(902)
Changes in assets and liabilities, net of effects from acquisitions and divestitures	3,596)	(369)	(4,921)	(11,024)	798)	1,829)	(452)	(338)	3,247)	(602)	(2,401)	2,263)	(1,239)	(30)	(3)	(2,739)	(1,568)	3,499)	(3,154)	(3,015)
Adjustments to reconcile net earnings (loss) to cash flows from operating activities	2,193)	4,017)	(1,659)	(6,825)	3,552)	5,299)	947)	402)	3,814)	(18,539)	(962)	3,325)	1,830)	1,826)	767)	(1,170)	996)	4,623)	(964)	(2,123)
Net cash flows from operating activities	7,309)	9,169)	3,878)	4,174)	6,983)	7,993)	5,633)	3,657)	7,863)	7,489)	4,182)	3,257)	5,350)	6,284)	5,581)	3,979)	5,732)	8,290)	5,314)	4,074)
Additions to property, plant and equipment	(1,837)	(1,157)	(1,043)	(795)	(1,612)	(1,029)	(976)	(807)	(1,589)	(967)	(1,124)	(863)	(1,587)	(952)	(863)	(607)	(1,415)	(747)	(813)	(677)
Proceeds from the disposal of assets/businesses, net	312)	76)	53)	279)	52)	50)	363)	210)	121)	121)	76)	40)	221)	8)	66)	248)	45)	12)	51)	603)
Acquisitions, net of cash acquired	(3,082)	(1)	(14,458)	—)	(1)	(338)	(12,996)	(1,811)	—)	—)	—)	—)	(17,130)	1)	(271)	(252)	(60)	—)	—)	—)
Acquired in-process research and development assets/related milestones	—)	(16)	(355)	(14)	(533)	(1,250)	—)	—)	(470)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Purchases of investments	(243)	(246)	(180)	(251)	(262)	(280)	(554)	(630)	(925)	(293)	(5,914)	(3,774)	(1,221)	(9,115)	(13,030)	(9,018)	(11,551)	(6,579)	(6,270)	(5,994)
Sales of investments	219)	489)	735)	218)	290)	466)	727)	979)	3,603)	3,910)	4,111)	7,766)	15,285)	8,690)	11,331)	6,303)	8,197)	4,356)	7,220)	5,233)
Credit support agreements activity, net	209)	346)	(2,980)	296)	818)	(731)	(170)	1,600)	(2,046)	(119)	(956)	158)	56)	(295)	239)	(249)	(482)	255)	(310)	751)
Other, including capitalized licenses and milestones	(63)	(33)	(36)	(30)	(72)	(16)	(81)	(5)	104)	(111)	31)	(12)	(21)	(38)	(111)	(59)	(94)	(16)	(297)	(101)
Net cash (used by) from investing activities	(4,485)	(542)	(18,264)	(297)	(1,320)	(3,128)	(13,687)	(464)	(1,202)	2,541)	(3,776)	3,315)	(4,397)	(1,701)	(2,639)	(3,634)	(5,360)	(2,719)	(419)	(185)
Dividends to shareholders	(3,131)	(3,132)	(3,129)	(2,989)	(2,984)	(2,985)	(2,985)	(2,869)	(2,865)	(2,871)	(3,092)	(2,942)	(2,954)	(2,970)	(2,971)	(2,787)	(2,791)	(2,791)	(2,791)	(2,659)
Repurchase of common stock	(1,924)	(1,902)	—)	(2,127)	(282)	(539)	(136)	(1,475)	(216)	(920)	(381)	(3,537)	(1,320)	(2,165)	(973)	(1,577)	(996)	(391)	(631)	(1,438)
Proceeds from short-term debt, net	3,913)	1,324)	565)	8,784)	3,293)	(1,992)	8,713)	5,263)	1,281)	241)	1,127)	11,094)	9,035)	2,728)	1,352)	3,019)	714)	785)	475)	23)
Repayment of short-term debt, net	(1,806)	(5,466)	(2,938)	(2,120)	(1,109)	(4,439)	(3,025)	(890)	(1,328)	(8,034)	(8,223)	(5,388)	(1,742)	(2,607)	(1,345)	(856)	(369)	(132)	(214)	(475)
Proceeds from long-term debt, net of issuance costs	—)	—)	—)	9,138)	—)	1)	6,657)	2)	—)	—)	—)	—)	1)	(1)	2)	—)	2)	2)	—)	1)
Repayment of long-term debt	(2)	(1,001)	(3)	(751)	(649)	(1)	(802)	(1)	(1,049)	(1)	(1)	(500)	(1)	(1)	—)	(2,132)	(350)	(1)	(450)	(1,001)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net	1,587)	1,274)	107)	450)	124)	424)	95)	195)	187)	653)	265)	(11)	422)	87)	499)	321)	228)	265)	307)	236)
Credit support agreements activity, net	20)	25)	(268)	(3)	267)	(276)	53)	228)	(281)	188)	(113)	(13)	(1,706)	865)	1,048)	(235)	113)	38)	(82)	212)
Settlement of convertible debt acquired from Shockwave	—)	—)	—)	—)	—)	—)	(970)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation	—)	—)	—)	—)	—)	—)	—)	—)	—)	373)	—)	7,674)	—)	—)	—)	—)	—)	—)	—)	—)
Proceeds from Kenvue initial public offering	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	4,241)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Cash transferred to Kenvue at separation	—)	—)	—)	—)	—)	—)	—)	—)	—)	(1,114)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other	(26)	(49)	1)	40)	—)	(75)	(56)	93)	(384)	168)	186)	(239)	(35)	139)	127)	(138)	13)	18)	107)	(24)
Net cash from (used by) financing activities	(1,369)	(8,927)	(5,665)	10,422)	(1,340)	(9,882)	7,544)	546)	(4,655)	(11,317)	(5,991)	6,138)	1,700)	(3,925)	(2,261)	(4,385)	(3,436)	(2,207)	(3,279)	(5,125)
Effect of exchange rate changes on cash and cash equivalents	23)	(46)	154)	70)	(198)	119)	(85)	(125)	125)	(168)	(97)	28)	119)	(286)	(161)	16)	(53)	(92)	45)	(78)
Increase (decrease) in cash and cash equivalents	1,478)	(346)	(19,897)	14,369)	4,125)	(4,898)	(595)	3,614)	2,131)	(1,455)	(5,682)	12,738)	2,772)	372)	520)	(4,024)	(3,117)	3,272)	1,661)	(1,314)

The financial information reveals fluctuating cash flows over the analyzed period, spanning from April 2021 to March 2025. Operating cash flows generally remained positive, though with considerable variation. Investing activities consistently represented a net cash outflow, driven primarily by purchases of investments and, in specific periods, acquisitions. Financing activities exhibited significant volatility, swinging between substantial net cash outflows and inflows, influenced by debt activity, stock repurchases, and dividend payments. A notable event impacting financing cash flows was the separation of Kenvue, resulting in significant cash transfers and proceeds from the initial public offering.

Net Earnings & Operating Cash Flow: Net earnings demonstrated variability, peaking in the October 2023 quarter at US$26,028 million, but experiencing a substantial loss in the April 2023 quarter (-US$68 million). Correspondingly, net cash flows from operating activities fluctuated, generally tracking net earnings, but remaining positive throughout the period. The highest operating cash flow occurred in the October 2023 quarter (US$7,489 million), while the lowest was observed in December 2021 (US$5,732 million). Adjustments to reconcile net earnings to cash flows from operating activities, including depreciation, amortization, and stock-based compensation, consistently contributed positive cash flow, while deferred tax provisions and changes in working capital often presented offsetting effects.
Investing Activities: Investing activities consistently consumed cash. Purchases of investments were a major driver of this outflow, with significant amounts recorded across all periods. Additions to property, plant, and equipment also contributed to the cash outflow. Proceeds from the disposal of assets/businesses provided some offsetting inflows, but were generally insufficient to counteract the outflows. The December 2022 quarter saw a particularly large outflow related to acquisitions (US$17,130 million). Asset write-downs also contributed to cash outflows in several quarters, notably in October 2021 (US$938 million) and December 2022 (US$429 million).
Financing Activities & Kenvue Separation: Financing activities were highly dynamic. Dividend payments and stock repurchases consistently represented significant cash outflows. Debt activity, including proceeds and repayments of both short-term and long-term debt, introduced substantial fluctuations. The separation of Kenvue in 2023 had a dramatic impact. The company experienced a significant cash outflow related to the transfer of assets to Kenvue, but also received substantial proceeds from the Kenvue initial public offering and related debt transactions. This resulted in a net cash inflow from financing activities in several quarters of 2023 and 2024. Prior to the Kenvue separation, financing cash flows were generally negative, driven by dividends and share repurchases.
Working Capital: Changes in working capital components exhibited considerable variability. Decreases in accounts receivable generally contributed to cash inflows, while increases represented outflows. Inventory fluctuations also impacted cash flow, with decreases typically generating inflows. Accounts payable and accrued liabilities demonstrated a more complex pattern, with both increases and decreases observed. The net effect of these working capital changes was often a significant factor influencing overall operating cash flow.
Overall Cash Position: The overall increase or decrease in cash and cash equivalents varied significantly throughout the period. Periods of positive net cash flow from operating and financing activities resulted in increases, while periods dominated by cash outflows from investing activities often led to decreases. The impact of the Kenvue separation was particularly pronounced, contributing to substantial cash inflows in certain quarters. Exchange rate changes had a relatively minor, though fluctuating, impact on cash balances.

AI Ask an analyst for more

Download chart

Johnson & Johnson (NYSE:JNJ)

Cash Flow Statement Quarterly Data

Cash Flow Statement
Quarterly Data